CystitisCyclophosphamideUrinary BladderAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic Agents, AlkylatingPhosphoramide MustardsVincristineDoxorubicinUrinary Bladder DiseasesPrednisoneImmunosuppressive AgentsCystoscopyMesnaMethotrexateHematuriaDrug Administration ScheduleAcroleinPulse Therapy, DrugUrotheliumBusulfanPelvic PainCombined Modality TherapyEtoposideEpirubicinTreatment OutcomePentosan Sulfuric PolyesterBK VirusPrednisoloneThiotepaPyelonephritisBone Marrow TransplantationHemorrhageBreast NeoplasmsRemission InductionAdministration, IntravesicalAntibodies, Monoclonal, Murine-DerivedVidarabineHematopoietic Stem Cell TransplantationFluorouracilMethylprednisoloneLeukopeniaGranulocyte Colony-Stimulating FactorPolyomavirus InfectionsLymphoma, Non-HodgkinDisease-Free SurvivalUrineUrinary Tract InfectionsTransplantation, AutologousDose-Response Relationship, DrugDrug Therapy, CombinationUrinary Bladder, OveractiveTransplantation ConditioningAdministration, MetronomicWhole-Body IrradiationAnti-Infective Agents, UrinaryChemotherapy, AdjuvantRecurrenceIfosfamideTime FactorsVulvodyniaSurvival AnalysisCarmustinePyelitisUrinationSurvival RateTransplantation, HomologousMelphalanUropathogenic Escherichia coliImmunosuppressionAzathioprineWegener GranulomatosisNitrofurantoinUroplakin IIFollow-Up StudiesLupus NephritisUroplakin IIIEscherichia coli InfectionsCisplatinAntineoplastic AgentsNeutropeniaChlorambucilProstatitisMitoxantroneBleomycinAdministration, OralAlkylating AgentsHematopoietic Stem Cell MobilizationUlcerBacteriuriaLeukocyte CountProcarbazine